Men's health news

HIV drug first to be approved in UK for pre-exposure prophylaxis

HIV drug first to be approved in UK for pre-exposure prophylaxis

Truvada (emtricitabine/tenofovir) is indicated in combination...

Aviptadil/phentolamine launched as combination treatment for erectile dysfunction

Aviptadil/phentolamine launched as combination treatment for erectile dysfunction

Invicorp (aviptadil/phentolamine) is a new combination...

Women-only constipation treatment now licensed in men

Women-only constipation treatment now licensed in men

Prescribers can now consider the 5HT4 agonist prucalopride...

Xiapex now indicated in Peyronie's disease

Xiapex now indicated in Peyronie's disease

Xiapex (collagenase) is licensed to treat Peyronie's...

Prescribing restrictions for generic sildenafil removed

Prescribing restrictions for generic sildenafil removed

The Department of Health has removed restrictions requiring...

Prolia approved for male osteoporosis

Prolia approved for male osteoporosis

Prolia (denosumab) can now be prescribed in men with...

Vitaros: a new topical treatment for erectile dysfunction

Vitaros: a new topical treatment for erectile dysfunction

Vitaros, a topical cream formulation of alprostadil,...

Spedra launch provides new option for erectile dysfunction

Spedra launch provides new option for erectile dysfunction

Spedra (avanafil), a new PDE5 inhibitor, has been launched...

Vesomni: combination tablet for urinary storage symptoms associated with BPH

Vesomni: combination tablet for urinary storage symptoms associated with BPH

Vesomni is a fixed-dose, modified-release combination...

Priligy: first licensed treatment for premature ejaculation

Priligy: first licensed treatment for premature ejaculation

Priligy (dapoxetine) is the first licensed treatment...

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi (enzalutamide) is an anti-androgen licensed...

Nipatra: chewable sildenafil tablet for erectile dysfunction

Nipatra: chewable sildenafil tablet for erectile dysfunction

Amdipharm Mercury has launched a chewable tablet formulation...

News in brief - August 2013

News in brief - August 2013

Other new launches, licence changes and updates relevant...

Zytiga approved for use before chemotherapy

Zytiga approved for use before chemotherapy

The licence for Zytiga (abiraterone) has been extended...

Cialis: first PDE5 inhibitor licensed for benign prostatic hyperplasia

Cialis: first PDE5 inhibitor licensed for benign prostatic hyperplasia

Tadalafil (Cialis) has been approved for the treatment...

NICE approval for denosumab in cancer

NICE approval for denosumab in cancer

The osteoclast-targeting antibody denosumab has been...

Zytiga launched for advanced prostate cancer

Zytiga launched for advanced prostate cancer

Zytiga (abiraterone) is indicated for use in combination...

Jevtana: new option for metastatic prostate cancer

Jevtana: new option for metastatic prostate cancer

Jevtana (cabazitaxel) is a novel taxane and is licensed...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.